Milano Vincent
SEC-identified person · CIK 1187159 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Biocryst Pharmaceuticals INC BCRX | Director | filed 2021 - 2026 |
| Aclaris Therapeutics, Inc. ACRS | Director | filed 2020 - 2026 |
| Idera Pharmaceuticals, INC. IDRA | Director · President and CEO | filed 2014 - 2023 |
| Spark Therapeutics, Inc. ONCE | Director | filed 2015 - 2019 |
| Vanda Pharmaceuticals Inc. VNDA | Director | filed 2010 - 2018 |
| Viropharma INC VPHM | Director · VP, COO & CFO | filed 2006 - 2014 |
| Verticalnet INC VERT | Director | filed 2006 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.